No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PAVMPAVmed Inc. | 7.64M | 8.29 | 16.71 | 22.15% | -217914.55% | -245.07% | ||
| SMLRSemler Scientific, Inc. | 310.9M | 20.34 | 3.96 | -17.44% | 130.8% | 10.51% | 0.00 | |
| BJDXBluejay Diagnostics, Inc. | 1.19M | 0.66 | -0.02 | -185.51% | 0.04 | |||
| HSCSHeartSciences Inc. | 9.63M | 3.03 | -0.32 | -76.61% | -1042.38% | -216.05% | 14.55 | |
| LUCDLucid Diagnostics Inc. | 156.01M | 1.19 | -1.13 | 79% | -8.6% | -404.1% | 3.94 | |
| BMRABiomerica, Inc. | 7.99M | 2.71 | -1.25 | -1.92% | -74.84% | -70.9% | 0.11 | |
| MDAISpectral AI, Inc. | 48.8M | 1.59 | -1.87 | 63.83% | -70.64% | |||
| CODXCo-Diagnostics, Inc. | 4.94M | 2.36 | -1.90 | -42.53% | -63.36% | -80.8% | 0.04 |
| Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 64.18K | 25.6K | 14.37K | 5.15K | 18.6K | 4.35K |
| Revenue Growth % | - | -0.6% | -0.44% | -0.64% | 2.61% | -0.77% |
| Cost of Goods Sold | 110.29K | 44.28K | 34.46K | 29.71K | 101.21K | 129.84K |
| COGS % of Revenue | 1.72% | 1.73% | 2.4% | 5.77% | 5.44% | 29.85% |
| Gross Profit | -46.1K | -18.67K | -20.08K | -24.56K | -82.61K | -125.48K |
| Gross Margin % | -0.72% | -0.73% | -1.4% | -4.77% | -4.44% | -28.85% |
| Gross Profit Growth % | - | 0.6% | -0.08% | -0.22% | -2.36% | -0.52% |
| Operating Expenses | 3.77M | 2.55M | 4.69M | 6.09M | 6.22M | 8.23M |
| OpEx % of Revenue | 58.77% | 99.57% | 326.26% | 1182.21% | 334.58% | 1891.28% |
| Selling, General & Admin | 1.73M | 841.01K | 1.69M | 3.63M | 3.34M | 3.84M |
| SG&A % of Revenue | 26.98% | 32.85% | 117.43% | 704.38% | 179.82% | 882.98% |
| Research & Development | 2.04M | 1.71M | 3M | 2.46M | 2.88M | 4.39M |
| R&D % of Revenue | 31.79% | 66.73% | 208.83% | 477.84% | 154.76% | 1008.3% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.82M | -2.57M | -4.71M | -6.11M | -6.31M | -8.35M |
| Operating Margin % | -59.49% | -100.3% | -327.66% | -1186.98% | -339.02% | -1920.13% |
| Operating Income Growth % | - | 0.33% | -0.83% | -0.3% | -0.03% | -0.32% |
| EBITDA | -3.75M | -2.53M | -4.68M | -6.09M | -6.21M | -8.22M |
| EBITDA Margin % | -58.5% | -98.99% | -325.81% | -1181.76% | -333.91% | -1890.72% |
| EBITDA Growth % | - | 0.32% | -0.85% | -0.3% | -0.02% | -0.32% |
| D&A (Non-Cash Add-back) | 63.83K | 33.61K | 26.57K | 26.91K | 95.13K | 127.96K |
| EBIT | -3.81M | -2.32M | -4.46M | -6.11M | -6.25M | -8.26M |
| Net Interest Income | -2.81K | -132.45K | -371.62K | -243.17K | -354.08K | -500.45K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.81K | 132.45K | 371.62K | 243.17K | 354.08K | 500.45K |
| Other Income/Expense | 7.07K | 115.96K | -118.86K | -241.33K | -299.44K | -412.66K |
| Pretax Income | -3.81M | -2.45M | -4.83M | -6.35M | -6.61M | -8.77M |
| Pretax Margin % | -59.38% | -95.77% | -335.93% | -1233.84% | -355.12% | -2015% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -3.81M | -2.45M | -4.83M | -6.35M | -6.61M | -8.77M |
| Net Margin % | -59.38% | -95.77% | -335.93% | -1233.84% | -355.12% | -2015% |
| Net Income Growth % | - | 0.36% | -0.97% | -0.32% | -0.04% | -0.33% |
| Net Income (Continuing) | -3.81M | -2.45M | -4.83M | -6.35M | -6.61M | -8.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -115.69 | -77.89 | -137.94 | -6173.88 | -18.74 | -9.34 |
| EPS Growth % | - | 0.33% | -0.77% | -43.76% | 1% | 0.5% |
| EPS (Basic) | -115.69 | -77.89 | -137.94 | -6173.88 | -18.74 | -9.34 |
| Diluted Shares Outstanding | 33.14K | 33.14K | 33.19K | 79.5K | 352.52K | 938.26K |
| Basic Shares Outstanding | 33.14K | 33.14K | 33.19K | 79.5K | 352.52K | 938.26K |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 1.54M | 1.64M | 1.93M | 2.7M | 7.35M | 2.17M |
| Cash & Short-Term Investments | 496.85K | 723.48K | 918.26K | 1.66M | 5.81M | 1.1M |
| Cash Only | 496.85K | 723.48K | 918.26K | 1.66M | 5.81M | 1.1M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 2.32K | 0 | 0 | 4.35K |
| Days Sales Outstanding | - | - | 58.94 | - | - | 365 |
| Inventory | 857.01K | 750.77K | 674.14K | 676.36K | 629.18K | 650.27K |
| Days Inventory Outstanding | 2.84K | 6.19K | 7.14K | 8.31K | 2.27K | 1.83K |
| Other Current Assets | 52.77K | 69.04K | 286.77K | 216.29K | 733.36K | 331.3K |
| Total Non-Current Assets | 418.05K | 289.33K | 158.57K | 590.65K | 2.15M | 2.05M |
| Property, Plant & Equipment | 418.05K | 289.33K | 158.57K | 590.65K | 559.97K | 435.18K |
| Fixed Asset Turnover | 0.15x | 0.09x | 0.09x | 0.01x | 0.03x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.59M | 1.62M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1.96M | 1.93M | 2.09M | 3.29M | 9.5M | 4.22M |
| Asset Turnover | 0.03x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | - | -0.01% | 0.08% | 0.57% | 1.89% | -0.56% |
| Total Current Liabilities | 1.14M | 1.11M | 3.47M | 1.83M | 1.75M | 3.7M |
| Accounts Payable | 358.79K | 335.78K | 694.75K | 631.37K | 448.18K | 318.66K |
| Days Payables Outstanding | 1.19K | 2.77K | 7.36K | 7.76K | 1.62K | 895.83 |
| Short-Term Debt | 350.77K | 380.2K | 1.63M | 500K | 500K | 2.55M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22K | 1.22K | 1.22K | 48.6K | 34.15K | 29.93K |
| Current Ratio | 1.35x | 1.47x | 0.56x | 1.47x | 4.20x | 0.59x |
| Quick Ratio | 0.60x | 0.80x | 0.36x | 1.10x | 3.84x | 0.41x |
| Cash Conversion Cycle | - | - | -159.34 | - | - | 1.3K |
| Total Non-Current Liabilities | 498.6K | 2.72M | 4.67M | 1.22M | 434.05K | 314.53K |
| Long-Term Debt | 300K | 2.5M | 4.44M | 500K | 0 | 0 |
| Capital Lease Obligations | 198.6K | 90.97K | 0 | 536.34K | 434.05K | 314.53K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 132.23K | 232.87K | 187.45K | 0 | 0 |
| Total Liabilities | 1.64M | 3.84M | 8.15M | 3.06M | 2.19M | 4.02M |
| Total Debt | 942.71K | 3.08M | 6.16M | 1.57M | 1.04M | 2.99M |
| Net Debt | 445.86K | 2.36M | 5.24M | -94.6K | -4.77M | 1.89M |
| Debt / Equity | 2.99x | - | - | 6.79x | 0.14x | 14.55x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -1358.30x | -19.39x | -12.67x | -25.14x | -17.81x | -16.69x |
| Total Equity | 315.55K | -1.91M | -6.06M | 230.56K | 7.32M | 205.17K |
| Equity Growth % | - | -7.05% | -2.17% | 1.04% | 30.74% | -0.97% |
| Book Value per Share | 9.52 | -57.63 | -182.46 | 2.90 | 20.76 | 0.22 |
| Total Shareholders' Equity | 315.55K | -1.91M | -6.06M | 230.56K | 7.32M | 205.17K |
| Common Stock | 3.31K | 3.31K | 3.32K | 101 | 677 | 1.12K |
| Retained Earnings | -47.12M | -49.57M | -54.4M | -60.76M | -67.36M | -76.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -3.84M | -2.45M | -3.64M | -5.77M | -6.07M | -7.41M |
| Operating CF Margin % | -59.83% | -95.78% | -253.54% | -1121.08% | -326.35% | -1704.14% |
| Operating CF Growth % | - | 0.36% | -0.49% | -0.58% | -0.05% | -0.22% |
| Net Income | -3.81M | -2.45M | -4.83M | -6.35M | -6.61M | -8.77M |
| Depreciation & Amortization | 63.83K | 33.61K | 26.57K | 26.91K | 95.13K | 127.96K |
| Stock-Based Compensation | 135.07K | 24.68K | 68.4K | 248.31K | 405.02K | 249.88K |
| Deferred Taxes | -10.02K | 0 | 0 | 101.1M | 0 | 0 |
| Other Non-Cash Items | -21.79K | -248.54K | -35.59K | -100.97M | 539.23K | 456.51K |
| Working Capital Changes | -195.97K | 190.13K | 1.12M | 173.98K | -504.36K | 517.89K |
| Change in Receivables | -7K | 0 | -2.32K | 2.32K | 0 | -4.35K |
| Change in Inventory | 147.31K | 106.23K | 76.64K | -2.22K | 47.18K | -21.09K |
| Change in Payables | -305.94K | -20.65K | 358.96K | 37.82K | -183.19K | -129.52K |
| Cash from Investing | 8.17K | -712 | -1.93K | -18.31K | -125.27K | -30.19K |
| Capital Expenditures | -11.42K | -712 | -1.93K | -18.31K | -64.45K | -3.16K |
| CapEx % of Revenue | 0.18% | 0.03% | 0.13% | 3.55% | 3.47% | 0.73% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 19.59K | 0 | 0 | 0 | -60.82K | -27.03K |
| Cash from Financing | 1.81M | 2.68M | 3.84M | 6.53M | 10.34M | 2.73M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | 0 | -385.14K | 1.31M | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -3.85M | -2.45M | -3.65M | -5.79M | -6.2M | -7.44M |
| FCF Margin % | -60.01% | -95.81% | -253.68% | -1124.64% | -333.09% | -1711.08% |
| FCF Growth % | - | 0.36% | -0.49% | -0.59% | -0.07% | -0.2% |
| FCF per Share | -116.22 | -74.02 | -109.86 | -72.85 | -17.57 | -7.93 |
| FCF Conversion (FCF/Net Income) | 1.01x | 1.00x | 0.75x | 0.91x | 0.92x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -1207.77% | - | - | -2756.06% | -175.02% | -233.04% |
| Return on Invested Capital (ROIC) | - | -319.12% | - | - | -352.68% | -270.12% |
| Gross Margin | -71.83% | -72.93% | -139.73% | -476.91% | -444.16% | -2884.71% |
| Net Margin | -5937.99% | -9577.29% | -33592.57% | -123384.27% | -35511.87% | -201499.52% |
| Debt / Equity | 2.99x | - | - | 6.79x | 0.14x | 14.55x |
| Interest Coverage | -1358.30x | -19.39x | -12.67x | -25.14x | -17.81x | -16.69x |
| FCF Conversion | 1.01x | 1.00x | 0.75x | 0.91x | 0.92x | 0.85x |
| Revenue Growth | - | -60.11% | -43.86% | -64.17% | 261.17% | -76.61% |
HeartSciences Inc. (HSCS) reported $0.0M in revenue for fiscal year 2025. This represents a 86% decrease from $0.1M in 2020.
HeartSciences Inc. (HSCS) saw revenue decline by 76.6% over the past year.
HeartSciences Inc. (HSCS) reported a net loss of $9.0M for fiscal year 2025.
HeartSciences Inc. (HSCS) has a return on equity (ROE) of -233.0%. Negative ROE indicates the company is unprofitable.
HeartSciences Inc. (HSCS) had negative free cash flow of $2.35B in fiscal year 2025, likely due to heavy capital investments.